Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement

Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave patients and doctors in a difficult position where an essential treatment or intervention has to be suspended. Even if virtually any intravenous medication can potentially trigger a life-threatening DHR, chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Cuesta, Emilio, Madrigal-Burgaleta, Ricardo, Broyles, Ana D., Cuesta-Herranz, Javier, Guzman-Melendez, Maria Antonieta, Maciag, Michelle C., Phillips, Elizabeth J., Trubiano, Jason A., Wong, Johnson T., Ansotegui, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163606/
https://www.ncbi.nlm.nih.gov/pubmed/35694005
http://dx.doi.org/10.1016/j.waojou.2022.100640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163606/
https://www.ncbi.nlm.nih.gov/pubmed/35694005
http://dx.doi.org/10.1016/j.waojou.2022.100640

Ejemplares similares